Equities
Health CareMedical Equipment and Services
  • Price (USD)234.27
  • Today's Change0.089 / 0.04%
  • Shares traded440.39k
  • 1 Year change-11.17%
  • Beta0.4347
Data delayed at least 15 minutes, as of Sep 16 2024 18:32 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Becton Dickinson and Co's net income fell -16.58% from 1.78bn to 1.48bn despite relatively flat revenues.
Gross margin45.35%
Net profit margin7.36%
Operating margin11.01%
Return on assets2.69%
Return on equity5.63%
Return on investment3.07%
More ▼

Cash flow in USDView more

In 2023, Becton Dickinson and Co increased its cash reserves by 27.78%, or 322.00m. The company earned 2.99bn from its operations for a Cash Flow Margin of 15.43%. In addition the company used 716.00m on investing activities and also paid 1.96bn in financing cash flows.
Cash flow per share12.85
Price/Cash flow per share18.07
Book value per share89.50
Tangible book value per share-29.71
More ▼

Balance sheet in USDView more

Becton Dickinson and Co has a Debt to Total Capital ratio of 42.76%, a lower figure than the previous year's 57.55%.
Current ratio1.85
Quick ratio1.36
Total debt/total equity0.747
Total debt/total capital0.4276
More ▼

Growth rates in USD

Year on year, growth in dividends per share increased 4.60% while earnings per share excluding extraordinary items fell by -5.19%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)1.38%
Div growth rate (5 year)3.94%
Payout ratio (TTM)74.64%
EPS growth(5 years)11.04
EPS (TTM) vs
TTM 1 year ago
-9.17
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.